0	0.1186/1475-2867-12-21	"<html>
 <body>
  <italic>
   cis
  </italic>
  -diamminedichloroplatinum (II)
  <def-item>
   <term>
    CX3CL1
   </term>
   <def>
    <p>
     Fractalkine
    </p>
   </def>
  </def-item>
  <def-item>
   <term>
    CXCL5
   </term>
   <def>
    <p>
     C-X-C motif chemokine 5
    </p>
   </def>
  </def-item>
  <def-item>
   <term>
    FasL
   </term>
   <def>
    <p>
     Fas ligand
    </p>
   </def>
  </def-item>
  <def-item>
   <term>
    H&amp;E
   </term>
   <def>
    <p>
     Hematoxylin and eosin
    </p>
   </def>
  </def-item>
  <def-item>
   <term>
    IFN-γ
   </term>
   <def>
    <p>
     Interferon gamma
    </p>
   </def>
  </def-item>
  <def-item>
   <term>
    IHC
   </term>
   <def>
    <p>
     Immunohistochemistry
    </p>
   </def>
  </def-item>
  <def-item>
   <term>
    IL
   </term>
   <def>
    <p>
     Interleukin
    </p>
   </def>
  </def-item>
  <def-item>
   <term>
    MHC-I
   </term>
   <def>
    <p>
     Class I major histocompatibility complex
    </p>
   </def>
  </def-item>
  <def-item>
   <term>
    MTT
   </term>
   <def>
    <p>
     3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
    </p>
   </def>
  </def-item>
  <def-item>
   <term>
    NK
   </term>
   <def>
    <p>
     Natural killer
    </p>
   </def>
  </def-item>
  <def-item>
   <term>
    NSCLC
   </term>
   <def>
    <p>
     Non-small-cell lung cancer
    </p>
   </def>
  </def-item>
  <def-item>
   <term>
    SCCA
   </term>
   <def>
    <p>
     Squamous cell carcinoma
    </p>
   </def>
  </def-item>
  <def-item>
   <term>
    SCF
   </term>
   <def>
    <p>
     Stem cell factor
    </p>
   </def>
  </def-item>
  <def-item>
   <term>
    SCLC
   </term>
   <def>
    <p>
     Small-cell lung cancer
    </p>
   </def>
  </def-item>
  <def-item>
   <term>
    Th1
   </term>
   <def>
    <p>
     T helper type I
    </p>
   </def>
  </def-item>
  <def-item>
   <term>
    Th17
   </term>
   <def>
    <p>
     T helper type 17
    </p>
   </def>
  </def-item>
  <def-item>
   <term>
    TNF-α
   </term>
   <def>
    <p>
     Tumor necrosis factor alpha
    </p>
   </def>
  </def-item>
  <ack>
   <p>
    We are very grateful to a professor Chung-Hung Tsai for histological analysis.
   </p>
   <sec id=""FPar1"">
    <title>
     Funding
    </title>
    <p>
     This study was supported by Grant 99-CSMU36 from Chung Shan Medical University, Taiwan.
    </p>
   </sec>
   <sec id=""FPar2"">
    <title>
     Availability of data and materials
    </title>
    <p>
     All data of this study is included in this article.
    </p>
   </sec>
   <sec id=""FPar3"">
    <title>
     Authors’ contributions
    </title>
    <p>
     MHC, MSJ and JHT performed the laboratory work, conducted the statistical analysis and were major contributors to the writing of the manuscript. MSJ provided academic recommendations regarding immunology. FJL and JTC provided advice regarding research questions and technological support. All authors read and approved the final manuscript.
    </p>
   </sec>
   <sec id=""FPar4"">
    <title>
     Competing interests
    </title>
    <p>
     The authors declare that they have no competing interests.
    </p>
   </sec>
   <sec id=""FPar5"">
    <title>
     Consent for publication
    </title>
    <p>
     Not applicable.
    </p>
   </sec>
   <sec id=""FPar6"">
    <title>
     Ethics approval and consent to participate
    </title>
    <p>
     All the experimental procedures were approved by the Institutional Animal Care and Use Committee of Chung Shan Medical University.
    </p>
   </sec>
   <sec id=""FPar7"">
    <title>
     Publisher’s Note
    </title>
    <p>
     Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
    </p>
   </sec>
  </ack>
  <ref-list id=""Bib1"">
   <title>
    References
   </title>
   <ref id=""CR1"">
    <label>
     1.
    </label>
    <element-citation publication-type=""journal"">
     <person-group person-group-type=""author"">
      <name>
       <surname>
        Siegel
       </surname>
       <given-names>
        R
       </given-names>
      </name>
      <name>
       <surname>
        Ma
       </surname>
       <given-names>
        J
       </given-names>
      </name>
      <name>
       <surname>
        Zou
       </surname>
       <given-names>
        Z
       </given-names>
      </name>
      <name>
       <surname>
        Jemal
       </surname>
       <given-names>
        A
       </given-names>
      </name>
     </person-group>
     <article-title>
      Cancer statistics, 2014
     </article-title>
     <source>
      CA Cancer J Clin
     </source>
     <year>
      2014
     </year>
     <volume>
      64
     </volume>
     <fpage>
      9
     </fpage>
     <lpage>
      29
     </lpage>
     <pub-id pub-id-type=""doi"">
      10.3322/caac.21208
     </pub-id>
     <pub-id pub-id-type=""pmid"">
      24399786
     </pub-id>
    </element-citation>
   </ref>
   <ref id=""CR2"">
    <label>
     2.
    </label>
    <element-citation publication-type=""journal"">
     <person-group person-group-type=""author"">
      <name>
       <surname>
        Travis
       </surname>
       <given-names>
        WD
       </given-names>
      </name>
      <name>
       <surname>
        Brambilla
       </surname>
       <given-names>
        E
       </given-names>
      </name>
      <name>
       <surname>
        Noguchi
       </surname>
       <given-names>
        M
       </given-names>
      </name>
      <name>
       <surname>
        Nicholson
       </surname>
       <given-names>
        AG
       </given-names>
      </name>
      <name>
       <surname>
        Geisinger
       </surname>
       <given-names>
        K
       </given-names>
      </name>
      <name>
       <surname>
        Yatabe
       </surname>
       <given-names>
        Y
       </given-names>
      </name>
      <name>
       <surname>
        Powell
       </surname>
       <given-names>
        CA
       </given-names>
      </name>
      <name>
       <surname>
        Beer
       </surname>
       <given-names>
        D
       </given-names>
      </name>
      <name>
       <surname>
        Riely
       </surname>
       <given-names>
        G
       </given-names>
      </name>
      <name>
       <surname>
        Garg
       </surname>
       <given-names>
        K
       </given-names>
      </name>
      <name>
       <surname>
        Austin
       </surname>
       <given-names>
        JH
       </given-names>
      </name>
      <name>
       <surname>
        Rusch
       </surname>
       <given-names>
        VW
       </given-names>
      </name>
      <name>
       <surname>
        Hirsch
       </surname>
       <given-names>
        FR
       </given-names>
      </name>
      <name>
       <surname>
        Jett
       </surname>
       <given-names>
        J
       </given-names>
      </name>
      <name>
       <surname>
        Yang
       </surname>
       <given-names>
        PC
       </given-names>
      </name>
      <name>
       <surname>
        Gould
       </surname>
       <given-names>
        M
       </given-names>
      </name>
      <collab>
       American Thoracic Society
      </collab>
     </person-group>
     <article-title>
      International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summary
     </article-title>
     <source>
      Proc Am Thorac Soc
     </source>
     <year>
      2011
     </year>
     <volume>
      8
     </volume>
     <fpage>
      381
     </fpage>
     <lpage>
      385
     </lpage>
     <pub-id pub-id-type=""doi"">
      10.1513/pats.201107-042ST
     </pub-id>
     <pub-id pub-id-type=""pmid"">
      21926387
     </pub-id>
    </element-citation>
   </ref>
   <ref id=""CR3"">
    <label>
     3.
    </label>
    <element-citation publication-type=""journal"">
     <person-group person-group-type=""author"">
      <name>
       <surname>
        Sun
       </surname>
       <given-names>
        S
       </given-names>
      </name>
      <name>
       <surname>
        Schiller
       </surname>
       <given-names>
        JH
       </given-names>
      </name>
      <name>
       <surname>
        Gazdar
       </surname>
       <given-names>
        AF
       </given-names>
      </name>
     </person-group>
     <article-title>
      Lung cancer in never smokers--a different disease
     </article-title>
     <source>
      Nat Rev Cancer
     </source>
     <year>
      2007
     </year>
     <volume>
      7
     </volume>
     <fpage>
      778
     </fpage>
     <lpage>
      790
     </lpage>
     <pub-id pub-id-type=""doi"">
      10.1038/nrc2190
     </pub-id>
     <pub-id pub-id-type=""pmid"">
      17882278
     </pub-id>
    </element-citation>
   </ref>
   <ref id=""CR4"">
    <label>
     4.
    </label>
    <element-citation publication-type=""journal"">
     <person-group person-group-type=""author"">
      <name>
       <surname>
        Houghton
       </surname>
       <given-names>
        AM
       </given-names>
      </name>
     </person-group>
     <article-title>
      Mechanistic links between COPD and lung cancer
     </article-title>
     <source>
      Nat Rev Cancer
     </source>
     <year>
      2013
     </year>
     <volume>
      13
     </volume>
     <fpage>
      233
     </fpage>
     <lpage>
      245
     </lpage>
     <pub-id pub-id-type=""doi"">
      10.1038/nrc3477
     </pub-id>
     <pub-id pub-id-type=""pmid"">
      23467302
     </pub-id>
    </element-citation>
   </ref>
   <ref id=""CR5"">
    <label>
     5.
    </label>
    <element-citation publication-type=""journal"">
     <person-group person-group-type=""author"">
      <name>
       <surname>
        Spira
       </surname>
       <given-names>
        A
       </given-names>
      </name>
      <name>
       <surname>
        Beane
       </surname>
       <given-names>
        J
       </given-names>
      </name>
      <name>
       <surname>
        Shah
       </surname>
       <given-names>
        V
       </given-names>
      </name>
      <name>
       <surname>
        Liu
       </surname>
       <given-names>
        G
       </given-names>
      </name>
      <name>
       <surname>
        Schembri
       </surname>
       <given-names>
        F
       </given-names>
      </name>
      <name>
       <surname>
        Yang
       </surname>
       <given-names>
        X
       </given-names>
      </name>
      <name>
       <surname>
        Palma
       </surname>
       <given-names>
        J
       </given-names>
      </name>
      <name>
       <surname>
        Brody
       </surname>
       <given-names>
        JS
       </given-names>
      </name>
     </person-group>
     <article-title>
      Effects of cigarette smoke on the human airway epithelial cell transcriptome
     </article-title>
     <source>
      Proc Natl Acad Sci U S A
     </source>
     <year>
      2004
     </year>
     <volume>
      101
     </volume>
     <fpage>
      10143
     </fpage>
     <lpage>
      10148
     </lpage>
     <pub-id pub-id-type=""doi"">
      10.1073/pnas.0401422101
     </pub-id>
     <pub-id pub-id-type=""pmid"">
      15210990
     </pub-id>
    </element-citation>
   </ref>
   <ref id=""CR6"">
    <label>
     6.
    </label>
    <element-citation publication-type=""journal"">
     <person-group person-group-type=""author"">
      <name>
       <surname>
        Mao
       </surname>
       <given-names>
        L
       </given-names>
      </name>
      <name>
       <surname>
        Lee
       </surname>
       <given-names>
        JS
       </given-names>
      </name>
      <name>
       <surname>
        Kurie
       </surname>
       <given-names>
        JM
       </given-names>
      </name>
      <name>
       <surname>
        Fan
       </surname>
       <given-names>
        YH
       </given-names>
      </name>
      <name>
       <surname>
        Lippman
       </surname>
       <given-names>
        SM
       </given-names>
      </name>
      <name>
       <surname>
        Lee
       </surname>
       <given-names>
        JJ
       </given-names>
      </name>
      <name>
       <surname>
        Ro
       </surname>
       <given-names>
        JY
       </given-names>
      </name>
      <name>
       <surname>
        Broxson
       </surname>
       <given-names>
        A
       </given-names>
      </name>
      <name>
       <surname>
        Yu
       </surname>
       <given-names>
        R
       </given-names>
      </name>
      <name>
       <surname>
        Morice
       </surname>
       <given-names>
        RC
       </given-names>
      </name>
      <name>
       <surname>
        Kemp
       </surname>
       <given-names>
        BL
       </given-names>
      </name>
      <name>
       <surname>
        Khuri
       </surname>
       <given-names>
        FR
       </given-names>
      </name>
      <name>
       <surname>
        Walsh
       </surname>
       <given-names>
        GL
       </given-names>
      </name>
      <name>
       <surname>
        Hittelman
       </surname>
       <given-names>
        WN
       </given-names>
      </name>
      <name>
       <surname>
        Hong
       </surname>
       <given-names>
        WK
       </given-names>
      </name>
     </person-group>
     <article-title>
      Clonal genetic alterations in the lungs of current and former smokers
     </article-title>
     <source>
      J Natl Cancer Inst
     </source>
     <year>
      1997
     </year>
     <volume>
      89
     </volume>
     <fpage>
      857
     </fpage>
     <lpage>
      862
     </lpage>
     <pub-id pub-id-type=""doi"">
      10.1093/jnci/89.12.857
     </pub-id>
     <pub-id pub-id-type=""pmid"">
      9196251
     </pub-id>
    </element-citation>
   </ref>
   <ref id=""CR7"">
    <label>
     7.
    </label>
    <element-citation publication-type=""journal"">
     <person-group person-group-type=""author"">
      <name>
       <surname>
        Lebwohl
       </surname>
       <given-names>
        D
       </given-names>
      </name>
      <name>
       <surname>
        Canetta
       </surname>
       <given-names>
        R
       </given-names>
      </name>
     </person-group>
     <article-title>
      Clinical development of platinum complexes in cancer therapy: an historical perspective and an update
     </article-title>
     <source>
      Eur J Cancer
     </source>
     <year>
      1998
     </year>
     <volume>
      34
     </volume>
     <fpage>
      1522
     </fpage>
     <lpage>
      1534
     </lpage>
     <pub-id pub-id-type=""doi"">
      10.1016/S0959-8049(98)00224-X
     </pub-id>
     <pub-id pub-id-type=""pmid"">
      9893623
     </pub-id>
    </element-citation>
   </ref>
   <ref id=""CR8"">
    <label>
     8.
    </label>
    <element-citation publication-type=""journal"">
     <person-group person-group-type=""author"">
      <name>
       <surname>
        Chirino
       </surname>
       <given-names>
        YI
       </given-names>
      </name>
      <name>
       <surname>
        Pedraza-Chaverri
       </surname>
       <given-names>
        J
       </given-names>
      </name>
     </person-group>
     <article-title>
      Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity
     </article-title>
     <source>
      Exp Toxicol Pathol
     </source>
     <year>
      2009
     </year>
     <volume>
      61
     </volume>
     <fpage>
      223
     </fpage>
     <lpage>
      242
     </lpage>
     <pub-id pub-id-type=""doi"">
      10.1016/j.etp.2008.09.003
     </pub-id>
     <pub-id pub-id-type=""pmid"">
      18986801
     </pub-id>
    </element-citation>
   </ref>
   <ref id=""CR9"">
    <label>
     9.
    </label>
    <element-citation publication-type=""journal"">
     <person-group person-group-type=""author"">
      <name>
       <surname>
        Lorusso
       </surname>
       <given-names>
        D
       </given-names>
      </name>
      <name>
       <surname>
        Petrelli
       </surname>
       <given-names>
        F
       </given-names>
      </name>
      <name>
       <surname>
        Coinu
       </surname>
       <given-names>
        A
       </given-names>
      </name>
      <name>
       <surname>
        Raspagliesi
       </surname>
       <given-names>
        F
       </given-names>
      </name>
      <name>
       <surname>
        Barni
       </surname>
       <given-names>
        S
       </given-names>
      </name>
     </person-group>
     <article-title>
      A systematic review comparing cisplatin and carboplatin plus paclitaxel-based chemotherapy for recurrent or metastatic cervical cancer
     </article-title>
     <source>
      Gynecol Oncol
     </source>
     <year>
      2014
     </year>
     <volume>
      133
     </volume>
     <fpage>
      117
     </fpage>
     <lpage>
      123
     </lpage>
     <pub-id pub-id-type=""doi"">
      10.1016/j.ygyno.2014.01.042
     </pub-id>
     <pub-id pub-id-type=""pmid"">
      24486604
     </pub-id>
    </element-citation>
   </ref>
   <ref id=""CR10"">
    <label>
     10.
    </label>
    <element-citation publication-type=""journal"">
     <person-group person-group-type=""author"">
      <name>
       <surname>
        Hagihara
       </surname>
       <given-names>
        A
       </given-names>
      </name>
      <name>
       <surname>
        Ikeda
       </surname>
       <given-names>
        M
       </given-names>
      </name>
      <name>
       <surname>
        Ueno
       </surname>
       <given-names>
        H
       </given-names>
      </name>
      <name>
       <surname>
        Morizane
       </surname>
       <given-names>
        C
       </given-names>
      </name>
      <name>
       <surname>
        Kondo
       </surname>
       <given-names>
        S
       </given-names>
      </name>
      <name>
       <surname>
        Nakachi
       </surname>
       <given-names>
        K
       </given-names>
      </name>
      <name>
       <surname>
        Mitsunaga
       </surname>
       <given-names>
        S
       </given-names>
      </name>
      <name>
       <surname>
        Shimizu
       </surname>
       <given-names>
        S
       </given-names>
      </name>
      <name>
       <surname>
        Kojima
       </surname>
       <given-names>
        Y
       </given-names>
      </name>
      <name>
       <surname>
        Suzuki
       </surname>
       <given-names>
        E
       </given-names>
      </name>
      <name>
       <surname>
        Katayama
       </surname>
       <given-names>
        K
       </given-names>
      </name>
      <name>
       <surname>
        Imanaka
       </surname>
       <given-names>
        K
       </given-names>
      </name>
      <name>
       <surname>
        Tamai
       </surname>
       <given-names>
        C
       </given-names>
      </name>
      <name>
       <surname>
        Inaba
       </surname>
       <given-names>
        Y
       </given-names>
      </name>
      <name>
       <surname>
        Sato
       </surname>
       <given-names>
        Y
       </given-names>
      </name>
      <name>
       <surname>
        Kato
       </surname>
       <given-names>
        M
       </given-names>
      </name>
      <name>
       <surname>
        Okusaka
       </surname>
       <given-names>
        T
       </given-names>
      </name>
     </person-group>
     <article-title>
      Phase I study of combination chemotherapy using sorafenib and transcatheter arterial infusion with cisplatin for advanced hepatocellular carcinoma
     </article-title>
     <source>
      Cancer Sci
     </source>
     <year>
      2014
     </year>
     <volume>
      105
     </volume>
     <fpage>
      354
     </fpage>
     <lpage>
      358
     </lpage>
     <pub-id pub-id-type=""doi"">
      10.1111/cas.12353
     </pub-id>
     <pub-id pub-id-type=""pmid"">
      24438504
     </pub-id>
    </element-citation>
   </ref>
   <ref id=""CR11"">
    <label>
     11.
    </label>
    <element-citation publication-type=""journal"">
     <person-group person-group-type=""author"">
      <name>
       <surname>
        Herbst
       </surname>
       <given-names>
        RS
       </given-names>
      </name>
      <name>
       <surname>
        Arquette
       </surname>
       <given-names>
        M
       </given-names>
      </name>
      <name>
       <surname>
        Shin
       </surname>
       <given-names>
        DM
       </given-names>
      </name>
      <name>
       <surname>
        Dicke
       </surname>
       <given-names>
        K
       </given-names>
      </name>
      <name>
       <surname>
        Vokes
       </surname>
       <given-names>
        EE
       </given-names>
      </name>
      <name>
       <surname>
        Azarnia
       </surname>
       <given-names>
        N
       </given-names>
      </name>
      <name>
       <surname>
        Hong
       </surname>
       <given-names>
        WK
       </given-names>
      </name>
      <name>
       <surname>
        Kies
       </surname>
       <given-names>
        MS
       </given-names>
      </name>
     </person-group>
     <article-title>
      Phase II multicenter study of the epidermal growth factor receptor antibody cetuximab and cisplatin for recurrent and refractory squamous cell carcinoma of the head and neck
     </article-title>
     <source>
      J Clin Oncol
     </source>
     <year>
      2005
     </year>
     <volume>
      23
     </volume>
     <fpage>
      5578
     </fpage>
     <lpage>
      5587
     </lpage>
     <pub-id pub-id-type=""doi"">
      10.1200/JCO.2005.07.120
     </pub-id>
     <pub-id pub-id-type=""pmid"">
      16009949
     </pub-id>
    </element-citation>
   </ref>
   <ref id=""CR12"">
    <label>
     12.
    </label>
    <mixed-citation publication-type=""other"">
     Chuang M-H, Chang JT, Hsu L-J, Jan M-S, Lu F-J. Antitumor activity of the Chinese medicine JC-001 is mediated by immunomodulation in a murine model of hepatocellular carcinoma. Integr Cancer Ther. 2016. doi:10.1177/1534735416664173.
    </mixed-citation>
   </ref>
   <ref id=""CR13"">
    <label>
     13.
    </label>
    <element-citation publication-type=""journal"">
     <person-group person-group-type=""author"">
      <name>
       <surname>
        Hyakudomi
       </surname>
       <given-names>
        M
       </given-names>
      </name>
      <name>
       <surname>
        Matsubara
       </surname>
       <given-names>
        T
       </given-names>
      </name>
      <name>
       <surname>
        Hyakudomi
       </surname>
       <given-names>
        R
       </given-names>
      </name>
      <name>
       <surname>
        Yamamoto
       </surname>
       <given-names>
        T
       </given-names>
      </name>
      <name>
       <surname>
        Kinugasa
       </surname>
       <given-names>
        S
       </given-names>
      </name>
      <name>
       <surname>
        Yamanoi
       </surname>
       <given-names>
        A
       </given-names>
      </name>
      <name>
       <surname>
        Maruyama
       </surname>
       <given-names>
        R
       </given-names>
      </name>
      <name>
       <surname>
        Tanaka
       </surname>
       <given-names>
        T
       </given-names>
      </name>
     </person-group>
     <article-title>
      Increased expression of fractalkine is correlated with a better prognosis and an increased number of both CD8+ T cells and natural killer cells in gastric adenocarcinoma
     </article-title>
     <source>
      Ann Surg Oncol
     </source>
     <year>
      2008
     </year>
     <volume>
      15
     </volume>
     <fpage>
      1775
     </fpage>
     <lpage>
      1782
     </lpage>
     <pub-id pub-id-type=""doi"">
      10.1245/s10434-008-9876-3
     </pub-id>
     <pub-id pub-id-type=""pmid"">
      18363071
     </pub-id>
    </element-citation>
   </ref>
   <ref id=""CR14"">
    <label>
     14.
    </label>
    <element-citation publication-type=""journal"">
     <person-group person-group-type=""author"">
      <name>
       <surname>
        Park
       </surname>
       <given-names>
        MH
       </given-names>
      </name>
      <name>
       <surname>
        Lee
       </surname>
       <given-names>
        JS
       </given-names>
      </name>
      <name>
       <surname>
        Yoon
       </surname>
       <given-names>
        JH
       </given-names>
      </name>
     </person-group>
     <article-title>
      High expression of CX3CL1 by tumor cells correlates with a good prognosis and increased tumor-infiltrating CD8+ T cells, natural killer cells, and dendritic cells in breast carcinoma
     </article-title>
     <source>
      J Surg Oncol
     </source>
     <year>
      2012
     </year>
     <volume>
      106
     </volume>
     <fpage>
      386
     </fpage>
     <lpage>
      392
     </lpage>
     <pub-id pub-id-type=""doi"">
      10.1002/jso.23095
     </pub-id>
     <pub-id pub-id-type=""pmid"">
      22422195
     </pub-id>
    </element-citation>
   </ref>
   <ref id=""CR15"">
    <label>
     15.
    </label>
    <element-citation publication-type=""journal"">
     <person-group person-group-type=""author"">
      <name>
       <surname>
        Rengarajan
       </surname>
       <given-names>
        J
       </given-names>
      </name>
      <name>
       <surname>
        Szabo
       </surname>
       <given-names>
        SJ
       </given-names>
      </name>
      <name>
       <surname>
        Glimcher
       </surname>
       <given-names>
        LH
       </given-names>
      </name>
     </person-group>
     <article-title>
      Transcriptional regulation of Th1/Th2 polarization
     </article-title>
     <source>
      Immunol Today
     </source>
     <year>
      2000
     </year>
     <volume>
      21
     </volume>
     <fpage>
      479
     </fpage>
     <lpage>
      483
     </lpage>
     <pub-id pub-id-type=""doi"">
      10.1016/S0167-5699(00)01712-6
     </pub-id>
     <pub-id pub-id-type=""pmid"">
      11071525
     </pub-id>
    </element-citation>
   </ref>
   <ref id=""CR16"">
    <label>
     16.
    </label>
    <element-citation publication-type=""journal"">
     <person-group person-group-type=""author"">
      <name>
       <surname>
        Rossi
       </surname>
       <given-names>
        D
       </given-names>
      </name>
      <name>
       <surname>
        Zlotnik
       </surname>
       <given-names>
        A
       </given-names>
      </name>
     </person-group>
     <article-title>
      The biology of chemokines and their receptors
     </article-title>
     <source>
      Ann Rev Immunol
     </source>
     <year>
      2000
     </year>
     <volume>
      18
     </volume>
     <fpage>
      217
     </fpage>
     <lpage>
      242
     </lpage>
     <pub-id pub-id-type=""doi"">
      10.1146/annurev.immunol.18.1.217
     </pub-id>
     <pub-id pub-id-type=""pmid"">
      10837058
     </pub-id>
    </element-citation>
   </ref>
   <ref id=""CR17"">
    <label>
     17.
    </label>
    <element-citation publication-type=""journal"">
     <person-group person-group-type=""author"">
      <name>
       <surname>
        Sallusto
       </surname>
       <given-names>
        F
       </given-names>
      </name>
      <name>
       <surname>
        Lanzavecchia
       </surname>
       <given-names>
        A
       </given-names>
      </name>
      <name>
       <surname>
        Mackay
       </surname>
       <given-names>
        CR
       </given-names>
      </name>
     </person-group>
     <article-title>
      Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses
     </article-title>
     <source>
      Immunol Today
     </source>
     <year>
      1998
     </year>
     <volume>
      19
     </volume>
     <fpage>
      568
     </fpage>
     <lpage>
      574
     </lpage>
     <pub-id pub-id-type=""doi"">
      10.1016/S0167-5699(98)01346-2
     </pub-id>
     <pub-id pub-id-type=""pmid"">
      9864948
     </pub-id>
    </element-citation>
   </ref>
   <ref id=""CR18"">
    <label>
     18.
    </label>
    <element-citation publication-type=""journal"">
     <person-group person-group-type=""author"">
      <name>
       <surname>
        Yoneda
       </surname>
       <given-names>
        O
       </given-names>
      </name>
      <name>
       <surname>
        Imai
       </surname>
       <given-names>
        T
       </given-names>
      </name>
      <name>
       <surname>
        Nishimura
       </surname>
       <given-names>
        M
       </given-names>
      </name>
      <name>
       <surname>
        Miyaji
       </surname>
       <given-names>
        M
       </given-names>
      </name>
      <name>
       <surname>
        Mimori
       </surname>
       <given-names>
        T
       </given-names>
      </name>
      <name>
       <surname>
        Okazaki
       </surname>
       <given-names>
        T
       </given-names>
      </name>
      <name>
       <surname>
        Domae
       </surname>
       <given-names>
        N
       </given-names>
      </name>
      <name>
       <surname>
        Fujimoto
       </surname>
       <given-names>
        H
       </given-names>
      </name>
      <name>
       <surname>
        Minami
       </surname>
       <given-names>
        Y
       </given-names>
      </name>
      <name>
       <surname>
        Kono
       </surname>
       <given-names>
        T
       </given-names>
      </name>
      <name>
       <surname>
        Bloom
       </surname>
       <given-names>
        ET
       </given-names>
      </name>
      <name>
       <surname>
        Umehara
       </surname>
       <given-names>
        H
       </given-names>
      </name>
     </person-group>
     <article-title>
      Membrane-bound form of fractalkine induces IFN-gamma production by NK cells
     </article-title>
     <source>
      Eur J Immunol
     </source>
     <year>
      2003
     </year>
     <volume>
      33
     </volume>
     <fpage>
      53
     </fpage>
     <lpage>
      58
     </lpage>
     <pub-id pub-id-type=""doi"">
      10.1002/immu.200390007
     </pub-id>
     <pub-id pub-id-type=""pmid"">
      12594832
     </pub-id>
    </element-citation>
   </ref>
   <ref id=""CR19"">
    <label>
     19.
    </label>
    <element-citation publication-type=""journal"">
     <person-group person-group-type=""author"">
      <name>
       <surname>
        Chin
       </surname>
       <given-names>
        YE
       </given-names>
      </name>
      <name>
       <surname>
        Kitagawa
       </surname>
       <given-names>
        M
       </given-names>
      </name>
      <name>
       <surname>
        Su
       </surname>
       <given-names>
        WC
       </given-names>
      </name>
      <name>
       <surname>
        You
       </surname>
       <given-names>
        ZH
       </given-names>
      </name>
      <name>
       <surname>
        Iwamoto
       </surname>
       <given-names>
        Y
       </given-names>
      </name>
      <name>
       <surname>
        Fu
       </surname>
       <given-names>
        XY
       </given-names>
      </name>
     </person-group>
     <article-title>
      Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1
     </article-title>
     <source>
      Science
     </source>
     <year>
      1996
     </year>
     <volume>
      272
     </volume>
     <fpage>
      719
     </fpage>
     <lpage>
      722
     </lpage>
     <pub-id pub-id-type=""doi"">
      10.1126/science.272.5262.719
     </pub-id>
     <pub-id pub-id-type=""pmid"">
      8614832
     </pub-id>
    </element-citation>
   </ref>
   <ref id=""CR20"">
    <label>
     20.
    </label>
    <element-citation publication-type=""journal"">
     <person-group person-group-type=""author"">
      <name>
       <surname>
        Dimco
       </surname>
       <given-names>
        G
       </given-names>
      </name>
      <name>
       <surname>
        Knight
       </surname>
       <given-names>
        RA
       </given-names>
      </name>
      <name>
       <surname>
        Latchman
       </surname>
       <given-names>
        DS
       </given-names>
      </name>
      <name>
       <surname>
        Stephanou
       </surname>
       <given-names>
        A
       </given-names>
      </name>
     </person-group>
     <article-title>
      STAT1 interacts directly with cyclin D1/Cdk4 and mediates cell cycle arrest
     </article-title>
     <source>
      Cell Cycle
     </source>
     <year>
      2010
     </year>
     <volume>
      9
     </volume>
     <fpage>
      4638
     </fpage>
     <lpage>
      4649
     </lpage>
     <pub-id pub-id-type=""doi"">
      10.4161/cc.9.23.13955
     </pub-id>
     <pub-id pub-id-type=""pmid"">
      21084836
     </pub-id>
    </element-citation>
   </ref>
   <ref id=""CR21"">
    <label>
     21.
    </label>
    <element-citation publication-type=""journal"">
     <person-group person-group-type=""author"">
      <name>
       <surname>
        O'Connell
       </surname>
       <given-names>
        J
       </given-names>
      </name>
      <name>
       <surname>
        Bennett
       </surname>
       <given-names>
        MW
       </given-names>
      </name>
      <name>
       <surname>
        Nally
       </surname>
       <given-names>
        K
       </given-names>
      </name>
      <name>
       <surname>
        O'Sullivan
       </surname>
       <given-names>
        GC
       </given-names>
      </name>
      <name>
       <surname>
        Collins
       </surname>
       <given-names>
        JK
       </given-names>
      </name>
      <name>
       <surname>
        Shanahan
       </surname>
       <given-names>
        F
       </given-names>
      </name>
     </person-group>
     <article-title>
      Interferon-gamma sensitizes colonic epithelial cell lines to physiological and therapeutic inducers of colonocyte apoptosis
     </article-title>
     <source>
      J Cell Physiol
     </source>
     <year>
      2000
     </year>
     <volume>
      185
     </volume>
     <fpage>
      331
     </fpage>
     <lpage>
      338
     </lpage>
     <pub-id pub-id-type=""doi"">
      10.1002/1097-4652(200012)185:3&lt;331::AID-JCP3&gt;3.0.CO;2-V
     </pub-id>
     <pub-id pub-id-type=""pmid"">
      11056003
     </pub-id>
    </element-citation>
   </ref>
   <ref id=""CR22"">
    <label>
     22.
    </label>
    <element-citation publication-type=""journal"">
     <person-group person-group-type=""author"">
      <name>
       <surname>
        Tura
       </surname>
       <given-names>
        BJ
       </given-names>
      </name>
      <name>
       <surname>
        Bunyan
       </surname>
       <given-names>
        KE
       </given-names>
      </name>
      <name>
       <surname>
        Harrison
       </surname>
       <given-names>
        DJ
       </given-names>
      </name>
     </person-group>
     <article-title>
      The effect of IFNgamma on the hepatocyte: cell cycle and apoptosis
     </article-title>
     <source>
      Int J Exp Pathol
     </source>
     <year>
      2001
     </year>
     <volume>
      82
     </volume>
     <fpage>
      317
     </fpage>
     <lpage>
      326
     </lpage>
     <pub-id pub-id-type=""doi"">
      10.1046/j.1365-2613.2001.00207.x
     </pub-id>
     <pub-id pub-id-type=""pmid"">
      11846838
     </pub-id>
    </element-citation>
   </ref>
   <ref id=""CR23"">
    <label>
     23.
    </label>
    <element-citation publication-type=""journal"">
     <person-group person-group-type=""author"">
      <name>
       <surname>
        Martini
       </surname>
       <given-names>
        M
       </given-names>
      </name>
      <name>
       <surname>
        Testi
       </surname>
       <given-names>
        MG
       </given-names>
      </name>
      <name>
       <surname>
        Pasetto
       </surname>
       <given-names>
        M
       </given-names>
      </name>
      <name>
       <surname>
        Picchio
       </surname>
       <given-names>
        MC
       </given-names>
      </name>
      <name>
       <surname>
        Innamorati
       </surname>
       <given-names>
        G
       </given-names>
      </name>
      <name>
       <surname>
        Mazzocco
       </surname>
       <given-names>
        M
       </given-names>
      </name>
      <name>
       <surname>
        Ugel
       </surname>
       <given-names>
        S
       </given-names>
      </name>
      <name>
       <surname>
        Cingarlini
       </surname>
       <given-names>
        S
       </given-names>
      </name>
      <name>
       <surname>
        Bronte
       </surname>
       <given-names>
        V
       </given-names>
      </name>
      <name>
       <surname>
        Zanovello
       </surname>
       <given-names>
        P
       </given-names>
      </name>
      <name>
       <surname>
        Krampera
       </surname>
       <given-names>
        M
       </given-names>
      </name>
      <name>
       <surname>
        Mosna
       </surname>
       <given-names>
        F
       </given-names>
      </name>
      <name>
       <surname>
        Cestari
       </surname>
       <given-names>
        T
       </given-names>
      </name>
      <name>
       <surname>
        Riviera
       </surname>
       <given-names>
        AP
       </given-names>
      </name>
      <name>
       <surname>
        Brutti
       </surname>
       <given-names>
        N
       </given-names>
      </name>
      <name>
       <surname>
        Barbieri
       </surname>
       <given-names>
        O
       </given-names>
      </name>
      <name>
       <surname>
        Matera
       </surname>
       <given-names>
        L
       </given-names>
      </name>
      <name>
       <surname>
        Tridente
       </surname>
       <given-names>
        G
       </given-names>
      </name>
      <name>
       <surname>
        Colombatti
       </surname>
       <given-names>
        M
       </given-names>
      </name>
      <name>
       <surname>
        Sartoris
       </surname>
       <given-names>
        S
       </given-names>
      </name>
     </person-group>
     <article-title>
      IFN-gamma-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancer
     </article-title>
     <source>
      Vaccine
     </source>
     <year>
      2010
     </year>
     <volume>
      28
     </volume>
     <fpage>
      3548
     </fpage>
     <lpage>
      3557
     </lpage>
     <pub-id pub-id-type=""doi"">
      10.1016/j.vaccine.2010.03.007
     </pub-id>
     <pub-id pub-id-type=""pmid"">
      20304037
     </pub-id>
    </element-citation>
   </ref>
   <ref id=""CR24"">
    <label>
     24.
    </label>
    <element-citation publication-type=""journal"">
     <person-group person-group-type=""author"">
      <name>
       <surname>
        Ando
       </surname>
       <given-names>
        S
       </given-names>
      </name>
      <name>
       <surname>
        Catalano
       </surname>
       <given-names>
        S
       </given-names>
      </name>
     </person-group>
     <article-title>
      The multifactorial role of leptin in driving the breast cancer microenvironment
     </article-title>
     <source>
      Nat Rev Endocrinol
     </source>
     <year>
      2012
     </year>
     <volume>
      8
     </volume>
     <fpage>
      263
     </fpage>
     <lpage>
      275
     </lpage>
     <pub-id pub-id-type=""doi"">
      10.1038/nrendo.2011.184
     </pub-id>
    </element-citation>
   </ref>
   <ref id=""CR25"">
    <label>
     25.
    </label>
    <element-citation publication-type=""journal"">
     <person-group person-group-type=""author"">
      <name>
       <surname>
        Fernandez-Riejos
       </surname>
       <given-names>
        P
       </given-names>
      </name>
      <name>
       <surname>
        Najib
       </surname>
       <given-names>
        S
       </given-names>
      </name>
      <name>
       <surname>
        Santos-Alvarez
       </surname>
       <given-names>
        J
       </given-names>
      </name>
      <name>
       <surname>
        Martin-Romero
       </surname>
       <given-names>
        C
       </given-names>
      </name>
      <name>
       <surname>
        Perez-Perez
       </surname>
       <given-names>
        A
       </given-names>
      </name>
      <name>
       <surname>
        Gonzalez-Yanes
       </surname>
       <given-names>
        C
       </given-names>
      </name>
      <name>
       <surname>
        Sanchez-Margalet
       </surname>
       <given-names>
        V
       </given-names>
      </name>
     </person-group>
     <article-title>
      Role of leptin in the activation of immune cells
     </article-title>
     <source>
      Mediat Inflamm
     </source>
     <year>
      2010
     </year>
     <volume>
      2010
     </volume>
     <fpage>
      568343
     </fpage>
     <pub-id pub-id-type=""doi"">
      10.1155/2010/568343
     </pub-id>
    </element-citation>
   </ref>
   <ref id=""CR26"">
    <label>
     26.
    </label>
    <element-citation publication-type=""journal"">
     <person-group person-group-type=""author"">
      <name>
       <surname>
        Lang
       </surname>
       <given-names>
        K
       </given-names>
      </name>
      <name>
       <surname>
        Ratke
       </surname>
       <given-names>
        J
       </given-names>
      </name>
     </person-group>
     <article-title>
      Leptin and Adiponectin: new players in the field of tumor cell and leukocyte migration
     </article-title>
     <source>
      Cell Commun Signal
     </source>
     <year>
      2009
     </year>
     <volume>
      7
     </volume>
     <fpage>
      27
     </fpage>
     <pub-id pub-id-type=""doi"">
      10.1186/1478-811X-7-27
     </pub-id>
     <pub-id pub-id-type=""pmid"">
      20030801
     </pub-id>
    </element-citation>
   </ref>
   <ref id=""CR27"">
    <label>
     27.
    </label>
    <element-citation publication-type=""journal"">
     <person-group person-group-type=""author"">
      <name>
       <surname>
        Maya-Monteiro
       </surname>
       <given-names>
        CM
       </given-names>
      </name>
      <name>
       <surname>
        Bozza
       </surname>
       <given-names>
        PT
       </given-names>
      </name>
     </person-group>
     <article-title>
      Leptin and mTOR: partners in metabolism and inflammation
     </article-title>
     <source>
      Cell Cycle
     </source>
     <year>
      2008
     </year>
     <volume>
      7
     </volume>
     <fpage>
      1713
     </fpage>
     <lpage>
      1717
     </lpage>
     <pub-id pub-id-type=""doi"">
      10.4161/cc.7.12.6157
     </pub-id>
     <pub-id pub-id-type=""pmid"">
      18583936
     </pub-id>
    </element-citation>
   </ref>
   <ref id=""CR28"">
    <label>
     28.
    </label>
    <element-citation publication-type=""journal"">
     <person-group person-group-type=""author"">
      <name>
       <surname>
        Zheng
       </surname>
       <given-names>
        Q
       </given-names>
      </name>
      <name>
       <surname>
        Dunlap
       </surname>
       <given-names>
        SM
       </given-names>
      </name>
      <name>
       <surname>
        Zhu
       </surname>
       <given-names>
        J
       </given-names>
      </name>
      <name>
       <surname>
        Downs-Kelly
       </surname>
       <given-names>
        E
       </given-names>
      </name>
      <name>
       <surname>
        Rich
       </surname>
       <given-names>
        J
       </given-names>
      </name>
      <name>
       <surname>
        Hursting
       </surname>
       <given-names>
        SD
       </given-names>
      </name>
      <name>
       <surname>
        Berger
       </surname>
       <given-names>
        NA
       </given-names>
      </name>
      <name>
       <surname>
        Reizes
       </surname>
       <given-names>
        O
       </given-names>
      </name>
     </person-group>
     <article-title>
      Leptin deficiency suppresses MMTV-Wnt-1 mammary tumor growth in obese mice and abrogates tumor initiating cell survival
     </article-title>
     <source>
      Endocr Relat Cancer
     </source>
     <year>
      2011
     </year>
     <volume>
      18
     </volume>
     <fpage>
      491
     </fpage>
     <lpage>
      503
     </lpage>
     <pub-id pub-id-type=""doi"">
      10.1530/ERC-11-0102
     </pub-id>
     <pub-id pub-id-type=""pmid"">
      21636700
     </pub-id>
    </element-citation>
   </ref>
   <ref id=""CR29"">
    <label>
     29.
    </label>
    <element-citation publication-type=""journal"">
     <person-group person-group-type=""author"">
      <name>
       <surname>
        Kuo
       </surname>
       <given-names>
        PL
       </given-names>
      </name>
      <name>
       <surname>
        Chen
       </surname>
       <given-names>
        YH
       </given-names>
      </name>
      <name>
       <surname>
        Chen
       </surname>
       <given-names>
        TC
       </given-names>
      </name>
      <name>
       <surname>
        Shen
       </surname>
       <given-names>
        KH
       </given-names>
      </name>
      <name>
       <surname>
        Hsu
       </surname>
       <given-names>
        YL
       </given-names>
      </name>
     </person-group>
     <article-title>
      CXCL5/ENA78 increased cell migration and epithelial-to-mesenchymal transition of hormone-independent prostate cancer by early growth response-1/snail signaling pathway
     </article-title>
     <source>
      J Cell Physiol
     </source>
     <year>
      2011
     </year>
     <volume>
      226
     </volume>
     <fpage>
      1224
     </fpage>
     <lpage>
      1231
     </lpage>
     <pub-id pub-id-type=""doi"">
      10.1002/jcp.22445
     </pub-id>
     <pub-id pub-id-type=""pmid"">
      20945384
     </pub-id>
    </element-citation>
   </ref>
   <ref id=""CR30"">
    <label>
     30.
    </label>
    <element-citation publication-type=""journal"">
     <person-group person-group-type=""author"">
      <name>
       <surname>
        Miyazaki
       </surname>
       <given-names>
        H
       </given-names>
      </name>
      <name>
       <surname>
        Patel
       </surname>
       <given-names>
        V
       </given-names>
      </name>
      <name>
       <surname>
        Wang
       </surname>
       <given-names>
        H
       </given-names>
      </name>
      <name>
       <surname>
        Edmunds
       </surname>
       <given-names>
        RK
       </given-names>
      </name>
      <name>
       <surname>
        Gutkind
       </surname>
       <given-names>
        JS
       </given-names>
      </name>
      <name>
       <surname>
        Yeudall
       </surname>
       <given-names>
        WA
       </given-names>
      </name>
     </person-group>
     <article-title>
      Down-regulation of CXCL5 inhibits squamous carcinogenesis
     </article-title>
     <source>
      Cancer Res
     </source>
     <year>
      2006
     </year>
     <volume>
      66
     </volume>
     <fpage>
      4279
     </fpage>
     <lpage>
      4284
     </lpage>
     <pub-id pub-id-type=""doi"">
      10.1158/0008-5472.CAN-05-4398
     </pub-id>
     <pub-id pub-id-type=""pmid"">
      16618752
     </pub-id>
    </element-citation>
   </ref>
   <ref id=""CR31"">
    <label>
     31.
    </label>
    <element-citation publication-type=""journal"">
     <person-group person-group-type=""author"">
      <name>
       <surname>
        Kawamura
       </surname>
       <given-names>
        M
       </given-names>
      </name>
      <name>
       <surname>
        Toiyama
       </surname>
       <given-names>
        Y
       </given-names>
      </name>
      <name>
       <surname>
        Tanaka
       </surname>
       <given-names>
        K
       </given-names>
      </name>
      <name>
       <surname>
        Saigusa
       </surname>
       <given-names>
        S
       </given-names>
      </name>
      <name>
       <surname>
        Okugawa
       </surname>
       <given-names>
        Y
       </given-names>
      </name>
      <name>
       <surname>
        Hiro
       </surname>
       <given-names>
        J
       </given-names>
      </name>
      <name>
       <surname>
        Uchida
       </surname>
       <given-names>
        K
       </given-names>
      </name>
      <name>
       <surname>
        Mohri
       </surname>
       <given-names>
        Y
       </given-names>
      </name>
      <name>
       <surname>
        Inoue
       </surname>
       <given-names>
        Y
       </given-names>
      </name>
      <name>
       <surname>
        Kusunoki
       </surname>
       <given-names>
        M
       </given-names>
      </name>
     </person-group>
     <article-title>
      CXCL5, a promoter of cell proliferation, migration and invasion, is a novel serum prognostic marker in patients with colorectal cancer
     </article-title>
     <source>
      Eur J Cancer
     </source>
     <year>
      2012
     </year>
     <volume>
      48
     </volume>
     <fpage>
      2244
     </fpage>
     <lpage>
      2251
     </lpage>
     <pub-id pub-id-type=""doi"">
      10.1016/j.ejca.2011.11.032
     </pub-id>
     <pub-id pub-id-type=""pmid"">
      22197219
     </pub-id>
    </element-citation>
   </ref>
   <ref id=""CR32"">
    <label>
     32.
    </label>
    <element-citation publication-type=""journal"">
     <person-group person-group-type=""author"">
      <name>
       <surname>
        Li
       </surname>
       <given-names>
        A
       </given-names>
      </name>
      <name>
       <surname>
        King
       </surname>
       <given-names>
        J
       </given-names>
      </name>
      <name>
       <surname>
        Moro
       </surname>
       <given-names>
        A
       </given-names>
      </name>
      <name>
       <surname>
        Sugi
       </surname>
       <given-names>
        MD
       </given-names>
      </name>
      <name>
       <surname>
        Dawson
       </surname>
       <given-names>
        DW
       </given-names>
      </name>
      <name>
       <surname>
        Kaplan
       </surname>
       <given-names>
        J
       </given-names>
      </name>
      <name>
       <surname>
        Li
       </surname>
       <given-names>
        G
       </given-names>
      </name>
      <name>
       <surname>
        Lu
       </surname>
       <given-names>
        X
       </given-names>
      </name>
      <name>
       <surname>
        Strieter
       </surname>
       <given-names>
        RM
       </given-names>
      </name>
      <name>
       <surname>
        Burdick
       </surname>
       <given-names>
        M
       </given-names>
      </name>
      <name>
       <surname>
        Go
       </surname>
       <given-names>
        VL
       </given-names>
      </name>
      <name>
       <surname>
        Reber
       </surname>
       <given-names>
        HA
       </given-names>
      </name>
      <name>
       <surname>
        Eibl
       </surname>
       <given-names>
        G
       </given-names>
      </name>
      <name>
       <surname>
        Hines
       </surname>
       <given-names>
        OJ
       </given-names>
      </name>
     </person-group>
     <article-title>
      Overexpression of CXCL5 is associated with poor survival in patients with pancreatic cancer
     </article-title>
     <source>
      Am J Pathol
     </source>
     <year>
      2011
     </year>
     <volume>
      178
     </volume>
     <fpage>
      1340
     </fpage>
     <lpage>
      1349
     </lpage>
     <pub-id pub-id-type=""doi"">
      10.1016/j.ajpath.2010.11.058
     </pub-id>
     <pub-id pub-id-type=""pmid"">
      21356384
     </pub-id>
    </element-citation>
   </ref>
   <ref id=""CR33"">
    <label>
     33.
    </label>
    <element-citation publication-type=""journal"">
     <person-group person-group-type=""author"">
      <name>
       <surname>
        Zhou
       </surname>
       <given-names>
        SL
       </given-names>
      </name>
      <name>
       <surname>
        Dai
       </surname>
       <given-names>
        Z
       </given-names>
      </name>
      <name>
       <surname>
        Zhou
       </surname>
       <given-names>
        ZJ
       </given-names>
      </name>
      <name>
       <surname>
        Wang
       </surname>
       <given-names>
        XY
       </given-names>
      </name>
      <name>
       <surname>
        Yang
       </surname>
       <given-names>
        GH
       </given-names>
      </name>
      <name>
       <surname>
        Wang
       </surname>
       <given-names>
        Z
       </given-names>
      </name>
      <name>
       <surname>
        Huang
       </surname>
       <given-names>
        XW
       </given-names>
      </name>
      <name>
       <surname>
        Fan
       </surname>
       <given-names>
        J
       </given-names>
      </name>
      <name>
       <surname>
        Zhou
       </surname>
       <given-names>
        J
       </given-names>
      </name>
     </person-group>
     <article-title>
      Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma
     </article-title>
     <source>
      Hepatology
     </source>
     <year>
      2012
     </year>
     <volume>
      56
     </volume>
     <fpage>
      2242
     </fpage>
     <lpage>
      2254
     </lpage>
     <pub-id pub-id-type=""doi"">
      10.1002/hep.25907
     </pub-id>
     <pub-id pub-id-type=""pmid"">
      22711685
     </pub-id>
    </element-citation>
   </ref>
   <ref id=""CR34"">
    <label>
     34.
    </label>
    <element-citation publication-type=""journal"">
     <person-group person-group-type=""author"">
      <name>
       <surname>
        Gorelik
       </surname>
       <given-names>
        E
       </given-names>
      </name>
      <name>
       <surname>
        Lokshin
       </surname>
       <given-names>
        A
       </given-names>
      </name>
      <name>
       <surname>
        Levina
       </surname>
       <given-names>
        V
       </given-names>
      </name>
     </person-group>
     <article-title>
      Lung cancer stem cells as a target for therapy
     </article-title>
     <source>
      Anti Cancer Agents Med Chem
     </source>
     <year>
      2010
     </year>
     <volume>
      10
     </volume>
     <fpage>
      164
     </fpage>
     <lpage>
      171
     </lpage>
     <pub-id pub-id-type=""doi"">
      10.2174/187152010790909308
     </pub-id>
    </element-citation>
   </ref>
   <ref id=""CR35"">
    <label>
     35.
    </label>
    <element-citation publication-type=""journal"">
     <person-group person-group-type=""author"">
      <name>
       <surname>
        Bellone
       </surname>
       <given-names>
        G
       </given-names>
      </name>
      <name>
       <surname>
        Carbone
       </surname>
       <given-names>
        A
       </given-names>
      </name>
      <name>
       <surname>
        Sibona
       </surname>
       <given-names>
        N
       </given-names>
      </name>
      <name>
       <surname>
        Bosco
       </surname>
       <given-names>
        O
       </given-names>
      </name>
      <name>
       <surname>
        Tibaudi
       </surname>
       <given-names>
        D
       </given-names>
      </name>
      <name>
       <surname>
        Smirne
       </surname>
       <given-names>
        C
       </given-names>
      </name>
      <name>
       <surname>
        Martone
       </surname>
       <given-names>
        T
       </given-names>
      </name>
      <name>
       <surname>
        Gramigni
       </surname>
       <given-names>
        C
       </given-names>
      </name>
      <name>
       <surname>
        Camandona
       </surname>
       <given-names>
        M
       </given-names>
      </name>
      <name>
       <surname>
        Emanuelli
       </surname>
       <given-names>
        G
       </given-names>
      </name>
      <name>
       <surname>
        Rodeck
       </surname>
       <given-names>
        U
       </given-names>
      </name>
     </person-group>
     <article-title>
      Aberrant activation of c-kit protects colon carcinoma cells against apoptosis and enhances their invasive potential
     </article-title>
     <source>
      Cancer Res
     </source>
     <year>
      2001
     </year>
     <volume>
      61
     </volume>
     <fpage>
      2200
     </fpage>
     <lpage>
      2206
     </lpage>
     <pub-id pub-id-type=""pmid"">
      11280787
     </pub-id>
    </element-citation>
   </ref>
   <ref id=""CR36"">
    <label>
     36.
    </label>
    <element-citation publication-type=""journal"">
     <person-group person-group-type=""author"">
      <name>
       <surname>
        Yasuda
       </surname>
       <given-names>
        A
       </given-names>
      </name>
      <name>
       <surname>
        Sawai
       </surname>
       <given-names>
        H
       </given-names>
      </name>
      <name>
       <surname>
        Takahashi
       </surname>
       <given-names>
        H
       </given-names>
      </name>
      <name>
       <surname>
        Ochi
       </surname>
       <given-names>
        N
       </given-names>
      </name>
      <name>
       <surname>
        Matsuo
       </surname>
       <given-names>
        Y
       </given-names>
      </name>
      <name>
       <surname>
        Funahashi
       </surname>
       <given-names>
        H
       </given-names>
      </name>
      <name>
       <surname>
        Sato
       </surname>
       <given-names>
        M
       </given-names>
      </name>
      <name>
       <surname>
        Okada
       </surname>
       <given-names>
        Y
       </given-names>
      </name>
      <name>
       <surname>
        Takeyama
       </surname>
       <given-names>
        H
       </given-names>
      </name>
      <name>
       <surname>
        Manabe
       </surname>
       <given-names>
        T
       </given-names>
      </name>
     </person-group>
     <article-title>
      The stem cell factor/c-kit receptor pathway enhances proliferation and invasion of pancreatic cancer cells
     </article-title>
     <source>
      Mol Cancer
     </source>
     <year>
      2006
     </year>
     <volume>
      5
     </volume>
     <fpage>
      46
     </fpage>
     <pub-id pub-id-type=""doi"">
      10.1186/1476-4598-5-46
     </pub-id>
     <pub-id pub-id-type=""pmid"">
      17044945
     </pub-id>
    </element-citation>
   </ref>
   <ref id=""CR37"">
    <label>
     37.
    </label>
    <element-citation publication-type=""journal"">
     <person-group person-group-type=""author"">
      <name>
       <surname>
        Zhang
       </surname>
       <given-names>
        M
       </given-names>
      </name>
      <name>
       <surname>
        Ma
       </surname>
       <given-names>
        Q
       </given-names>
      </name>
      <name>
       <surname>
        Hu
       </surname>
       <given-names>
        H
       </given-names>
      </name>
      <name>
       <surname>
        Zhang
       </surname>
       <given-names>
        D
       </given-names>
      </name>
      <name>
       <surname>
        Li
       </surname>
       <given-names>
        J
       </given-names>
      </name>
      <name>
       <surname>
        Ma
       </surname>
       <given-names>
        G
       </given-names>
      </name>
      <name>
       <surname>
        Bhat
       </surname>
       <given-names>
        K
       </given-names>
      </name>
      <name>
       <surname>
        Wu
       </surname>
       <given-names>
        E
       </given-names>
      </name>
     </person-group>
     <article-title>
      Stem cell factor/c-kit signaling enhances invasion of pancreatic cancer cells via HIF-1alpha under normoxic condition
     </article-title>
     <source>
      Cancer Lett
     </source>
     <year>
      2011
     </year>
     <volume>
      303
     </volume>
     <fpage>
      108
     </fpage>
     <lpage>
      117
     </lpage>
     <pub-id pub-id-type=""doi"">
      10.1016/j.canlet.2011.01.017
     </pub-id>
     <pub-id pub-id-type=""pmid"">
      21320746
     </pub-id>
    </element-citation>
   </ref>
   <ref id=""CR38"">
    <label>
     38.
    </label>
    <element-citation publication-type=""journal"">
     <person-group person-group-type=""author"">
      <name>
       <surname>
        Huang
       </surname>
       <given-names>
        B
       </given-names>
      </name>
      <name>
       <surname>
        Lei
       </surname>
       <given-names>
        Z
       </given-names>
      </name>
      <name>
       <surname>
        Zhang
       </surname>
       <given-names>
        GM
       </given-names>
      </name>
      <name>
       <surname>
        Li
       </surname>
       <given-names>
        D
       </given-names>
      </name>
      <name>
       <surname>
        Song
       </surname>
       <given-names>
        C
       </given-names>
      </name>
      <name>
       <surname>
        Li
       </surname>
       <given-names>
        B
       </given-names>
      </name>
      <name>
       <surname>
        Liu
       </surname>
       <given-names>
        Y
       </given-names>
      </name>
      <name>
       <surname>
        Yuan
       </surname>
       <given-names>
        Y
       </given-names>
      </name>
      <name>
       <surname>
        Unkeless
       </surname>
       <given-names>
        J
       </given-names>
      </name>
      <name>
       <surname>
        Xiong
       </surname>
       <given-names>
        H
       </given-names>
      </name>
      <name>
       <surname>
        Feng
       </surname>
       <given-names>
        ZH
       </given-names>
      </name>
     </person-group>
     <article-title>
      SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment
     </article-title>
     <source>
      Blood
     </source>
     <year>
      2008
     </year>
     <volume>
      112
     </volume>
     <fpage>
      1269
     </fpage>
     <lpage>
      1279
     </lpage>
     <pub-id pub-id-type=""doi"">
      10.1182/blood-2008-03-147033
     </pub-id>
     <pub-id pub-id-type=""pmid"">
      18524989
     </pub-id>
    </element-citation>
   </ref>
   <ref id=""CR39"">
    <label>
     39.
    </label>
    <element-citation publication-type=""journal"">
     <person-group person-group-type=""author"">
      <name>
       <surname>
        Wei
       </surname>
       <given-names>
        JJ
       </given-names>
      </name>
      <name>
       <surname>
        Song
       </surname>
       <given-names>
        CW
       </given-names>
      </name>
      <name>
       <surname>
        Sun
       </surname>
       <given-names>
        LC
       </given-names>
      </name>
      <name>
       <surname>
        Yuan
       </surname>
       <given-names>
        Y
       </given-names>
      </name>
      <name>
       <surname>
        Li
       </surname>
       <given-names>
        D
       </given-names>
      </name>
      <name>
       <surname>
        Yan
       </surname>
       <given-names>
        B
       </given-names>
      </name>
      <name>
       <surname>
        Liao
       </surname>
       <given-names>
        SJ
       </given-names>
      </name>
      <name>
       <surname>
        Zhu
       </surname>
       <given-names>
        JH
       </given-names>
      </name>
      <name>
       <surname>
        Wang
       </surname>
       <given-names>
        Q
       </given-names>
      </name>
      <name>
       <surname>
        Zhang
       </surname>
       <given-names>
        GM
       </given-names>
      </name>
      <name>
       <surname>
        Feng
       </surname>
       <given-names>
        ZH
       </given-names>
      </name>
     </person-group>
     <article-title>
      SCF and TLR4 ligand cooperate to augment the tumor-promoting potential of mast cells
     </article-title>
     <source>
      Cancer Immunol Immunother
     </source>
     <year>
      2012
     </year>
     <volume>
      61
     </volume>
     <fpage>
      303
     </fpage>
     <lpage>
      312
     </lpage>
     <pub-id pub-id-type=""doi"">
      10.1007/s00262-011-1098-z
     </pub-id>
     <pub-id pub-id-type=""pmid"">
      21877248
     </pub-id>
    </element-citation>
   </ref>
   <ref id=""CR40"">
    <label>
     40.
    </label>
    <element-citation publication-type=""journal"">
     <person-group person-group-type=""author"">
      <name>
       <surname>
        Jelly
       </surname>
       <given-names>
        ND
       </given-names>
      </name>
      <name>
       <surname>
        Hussain
       </surname>
       <given-names>
        EJ
       </given-names>
       <suffix>
        II
       </suffix>
      </name>
      <name>
       <surname>
        Eremin
       </surname>
       <given-names>
        O
       </given-names>
      </name>
      <name>
       <surname>
        El-Sheemy
       </surname>
       <given-names>
        M
       </given-names>
      </name>
     </person-group>
     <article-title>
      The stem cell factor antibody enhances the chemotherapeutic effect of adriamycin on chemoresistant breast cancer cells
     </article-title>
     <source>
      Cancer Cell Int
     </source>
     <year>
      2012
     </year>
     <volume>
      12
     </volume>
     <fpage>
      21
     </fpage>
     <pub-id pub-id-type=""doi"">
      10.1186/1475-2867-12-21
     </pub-id>
     <pub-id pub-id-type=""pmid"">
      22642642
     </pub-id>
    </element-citation>
   </ref>
   <ref id=""CR41"">
    <label>
     41.
    </label>
    <element-citation publication-type=""journal"">
     <person-group person-group-type=""author"">
      <name>
       <surname>
        Lu
       </surname>
       <given-names>
        C
       </given-names>
      </name>
      <name>
       <surname>
        Hassan
       </surname>
       <given-names>
        HT
       </given-names>
      </name>
     </person-group>
     <article-title>
      Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells
     </article-title>
     <source>
      Leuk Res
     </source>
     <year>
      2006
     </year>
     <volume>
      30
     </volume>
     <fpage>
      296
     </fpage>
     <lpage>
      302
     </lpage>
     <pub-id pub-id-type=""doi"">
      10.1016/j.leukres.2005.06.026
     </pub-id>
     <pub-id pub-id-type=""pmid"">
      16112192
     </pub-id>
    </element-citation>
   </ref>
   <ref id=""CR42"">
    <label>
     42.
    </label>
    <element-citation publication-type=""journal"">
     <person-group person-group-type=""author"">
      <name>
       <surname>
        Middleton
       </surname>
       <given-names>
        GW
       </given-names>
      </name>
      <name>
       <surname>
        Annels
       </surname>
       <given-names>
        NE
       </given-names>
      </name>
      <name>
       <surname>
        Pandha
       </surname>
       <given-names>
        HS
       </given-names>
      </name>
     </person-group>
     <article-title>
      Are we ready to start studies of Th17 cell manipulation as a therapy for cancer?
     </article-title>
     <source>
      Cancer Immunol Immunother
     </source>
     <year>
      2012
     </year>
     <volume>
      61
     </volume>
     <fpage>
      1
     </fpage>
     <lpage>
      7
     </lpage>
     <pub-id pub-id-type=""doi"">
      10.1007/s00262-011-1151-y
     </pub-id>
     <pub-id pub-id-type=""pmid"">
      22086162
     </pub-id>
    </element-citation>
   </ref>
   <ref id=""CR43"">
    <label>
     43.
    </label>
    <element-citation publication-type=""journal"">
     <person-group person-group-type=""author"">
      <name>
       <surname>
        Martin
       </surname>
       <given-names>
        F
       </given-names>
      </name>
      <name>
       <surname>
        Apetoh
       </surname>
       <given-names>
        L
       </given-names>
      </name>
      <name>
       <surname>
        Ghiringhelli
       </surname>
       <given-names>
        F
       </given-names>
      </name>
     </person-group>
     <article-title>
      Controversies on the role of Th17 in cancer: a TGF-beta-dependent immunosuppressive activity?
     </article-title>
     <source>
      Trends Mol Med
     </source>
     <year>
      2012
     </year>
     <volume>
      18
     </volume>
     <fpage>
      742
     </fpage>
     <lpage>
      749
     </lpage>
     <pub-id pub-id-type=""doi"">
      10.1016/j.molmed.2012.09.007
     </pub-id>
     <pub-id pub-id-type=""pmid"">
      23083809
     </pub-id>
    </element-citation>
   </ref>
   <ref id=""CR44"">
    <label>
     44.
    </label>
    <element-citation publication-type=""journal"">
     <person-group person-group-type=""author"">
      <name>
       <surname>
        Ouyang
       </surname>
       <given-names>
        W
       </given-names>
      </name>
      <name>
       <surname>
        Kolls
       </surname>
       <given-names>
        JK
       </given-names>
      </name>
      <name>
       <surname>
        Zheng
       </surname>
       <given-names>
        Y
       </given-names>
      </name>
     </person-group>
     <article-title>
      The biological functions of T helper 17 cell effector cytokines in inflammation
     </article-title>
     <source>
      Immunity
     </source>
     <year>
      2008
     </year>
     <volume>
      28
     </volume>
     <fpage>
      454
     </fpage>
     <lpage>
      467
     </lpage>
     <pub-id pub-id-type=""doi"">
      10.1016/j.immuni.2008.03.004
     </pub-id>
     <pub-id pub-id-type=""pmid"">
      18400188
     </pub-id>
    </element-citation>
   </ref>
   <ref id=""CR45"">
    <label>
     45.
    </label>
    <element-citation publication-type=""journal"">
     <person-group person-group-type=""author"">
      <name>
       <surname>
        Gregory
       </surname>
       <given-names>
        AD
       </given-names>
      </name>
      <name>
       <surname>
        Houghton
       </surname>
       <given-names>
        AM
       </given-names>
      </name>
     </person-group>
     <article-title>
      Tumor-associated neutrophils: new targets for cancer therapy
     </article-title>
     <source>
      Cancer Res
     </source>
     <year>
      2011
     </year>
     <volume>
      71
     </volume>
     <fpage>
      2411
     </fpage>
     <lpage>
      2416
     </lpage>
     <pub-id pub-id-type=""doi"">
      10.1158/0008-5472.CAN-10-2583
     </pub-id>
     <pub-id pub-id-type=""pmid"">
      21427354
     </pub-id>
    </element-citation>
   </ref>
   <ref id=""CR46"">
    <label>
     46.
    </label>
    <element-citation publication-type=""journal"">
     <person-group person-group-type=""author"">
      <name>
       <surname>
        Ramakrishnan
       </surname>
       <given-names>
        R
       </given-names>
      </name>
      <name>
       <surname>
        Assudani
       </surname>
       <given-names>
        D
       </given-names>
      </name>
      <name>
       <surname>
        Nagaraj
       </surname>
       <given-names>
        S
       </given-names>
      </name>
      <name>
       <surname>
        Hunter
       </surname>
       <given-names>
        T
       </given-names>
      </name>
      <name>
       <surname>
        Cho
       </surname>
       <given-names>
        HI
       </given-names>
      </name>
      <name>
       <surname>
        Antonia
       </surname>
       <given-names>
        S
       </given-names>
      </name>
      <name>
       <surname>
        Altiok
       </surname>
       <given-names>
        S
       </given-names>
      </name>
      <name>
       <surname>
        Celis
       </surname>
       <given-names>
        E
       </given-names>
      </name>
      <name>
       <surname>
        Gabrilovich
       </surname>
       <given-names>
        DI
       </given-names>
      </name>
     </person-group>
     <article-title>
      Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice
     </article-title>
     <source>
      J Clin Invest
     </source>
     <year>
      2010
     </year>
     <volume>
      120
     </volume>
     <fpage>
      1111
     </fpage>
     <lpage>
      1124
     </lpage>
     <pub-id pub-id-type=""doi"">
      10.1172/JCI40269
     </pub-id>
     <pub-id pub-id-type=""pmid"">
      20234093
     </pub-id>
    </element-citation>
   </ref>
   <ref id=""CR47"">
    <label>
     47.
    </label>
    <element-citation publication-type=""journal"">
     <person-group person-group-type=""author"">
      <name>
       <surname>
        Antonia
       </surname>
       <given-names>
        SJ
       </given-names>
      </name>
      <name>
       <surname>
        Mirza
       </surname>
       <given-names>
        N
       </given-names>
      </name>
      <name>
       <surname>
        Fricke
       </surname>
       <given-names>
        I
       </given-names>
      </name>
      <name>
       <surname>
        Chiappori
       </surname>
       <given-names>
        A
       </given-names>
      </name>
      <name>
       <surname>
        Thompson
       </surname>
       <given-names>
        P
       </given-names>
      </name>
      <name>
       <surname>
        Williams
       </surname>
       <given-names>
        N
       </given-names>
      </name>
      <name>
       <surname>
        Bepler
       </surname>
       <given-names>
        G
       </given-names>
      </name>
      <name>
       <surname>
        Simon
       </surname>
       <given-names>
        G
       </given-names>
      </name>
      <name>
       <surname>
        Janssen
       </surname>
       <given-names>
        W
       </given-names>
      </name>
      <name>
       <surname>
        Lee
       </surname>
       <given-names>
        JH
       </given-names>
      </name>
      <name>
       <surname>
        Menander
       </surname>
       <given-names>
        K
       </given-names>
      </name>
      <name>
       <surname>
        Chada
       </surname>
       <given-names>
        S
       </given-names>
      </name>
      <name>
       <surname>
        Gabrilovich
       </surname>
       <given-names>
        DI
       </given-names>
      </name>
     </person-group>
     <article-title>
      Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer
     </article-title>
     <source>
      Clin Cancer Res
     </source>
     <year>
      2006
     </year>
     <volume>
      12
     </volume>
     <fpage>
      878
     </fpage>
     <lpage>
      887
     </lpage>
     <pub-id pub-id-type=""doi"">
      10.1158/1078-0432.CCR-05-2013
     </pub-id>
     <pub-id pub-id-type=""pmid"">
      16467102
     </pub-id>
    </element-citation>
   </ref>
   <ref id=""CR48"">
    <label>
     48.
    </label>
    <element-citation publication-type=""journal"">
     <person-group person-group-type=""author"">
      <name>
       <surname>
        Arlen
       </surname>
       <given-names>
        PM
       </given-names>
      </name>
      <name>
       <surname>
        Gulley
       </surname>
       <given-names>
        JL
       </given-names>
      </name>
      <name>
       <surname>
        Parker
       </surname>
       <given-names>
        C
       </given-names>
      </name>
      <name>
       <surname>
        Skarupa
       </surname>
       <given-names>
        L
       </given-names>
      </name>
      <name>
       <surname>
        Pazdur
       </surname>
       <given-names>
        M
       </given-names>
      </name>
      <name>
       <surname>
        Panicali
       </surname>
       <given-names>
        D
       </given-names>
      </name>
      <name>
       <surname>
        Beetham
       </surname>
       <given-names>
        P
       </given-names>
      </name>
      <name>
       <surname>
        Tsang
       </surname>
       <given-names>
        KY
       </given-names>
      </name>
      <name>
       <surname>
        Grosenbach
       </surname>
       <given-names>
        DW
       </given-names>
      </name>
      <name>
       <surname>
        Feldman
       </surname>
       <given-names>
        J
       </given-names>
      </name>
      <name>
       <surname>
        Steinberg
       </surname>
       <given-names>
        SM
       </given-names>
      </name>
      <name>
       <surname>
        Jones
       </surname>
       <given-names>
        E
       </given-names>
      </name>
      <name>
       <surname>
        Chen
       </surname>
       <given-names>
        C
       </given-names>
      </name>
      <name>
       <surname>
        Marte
       </surname>
       <given-names>
        J
       </given-names>
      </name>
      <name>
       <surname>
        Schlom
       </surname>
       <given-names>
        J
       </given-names>
      </name>
      <name>
       <surname>
        Dahut
       </surname>
       <given-names>
        W
       </given-names>
      </name>
     </person-group>
     <article-title>
      A randomized phase II study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancer
     </article-title>
     <source>
      Clin Cancer Res
     </source>
     <year>
      2006
     </year>
     <volume>
      12
     </volume>
     <fpage>
      1260
     </fpage>
     <lpage>
      1269
     </lpage>
     <pub-id pub-id-type=""doi"">
      10.1158/1078-0432.CCR-05-2059
     </pub-id>
     <pub-id pub-id-type=""pmid"">
      16489082
     </pub-id>
    </element-citation>
   </ref>
  </ref-list>
  BMC_Complement_Altern_Med/PMC5389052.nxml                                                           0000664 0011011 0007774 00000266441 13074363723 016704  0                                                                                                    ustar   pmc                             pmcdev
  <!DOCTYPE article PUBLIC ""-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN"" ""JATS-archivearticle1.dtd"">
 </body>
</html>"
